Menu Search
Equities

Acadia Healthcare Company Inc

7RA:STU

Acadia Healthcare Company Inc

Actions
  • Price (EUR)48.80
  • Today's Change-0.20 / -0.41%
  • Shares traded0.00
  • 1 Year change+89.15%
  • Beta--
Data delayed at least 15 minutes, as of Oct 22 2021.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services in the United States. The Company is focused on acquiring and developing behavioral healthcare facilities. It is engaged in developing and operating inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States and Puerto Rico. The Company operates approximately 229 behavioral healthcare facilities with approximately 10,100 beds in 40 states and Puerto Rico. Its properties are located in Alaska, Arizona, California, Delaware, Florida, Georgia and others.

  • Revenue in USD (TTM)2.22bn
  • Net income in USD161.72m
  • Incorporated2005
  • Employees28.60k
  • Location
    Acadia Healthcare Company Inc6100 Tower Cir Ste 1000FRANKLIN 37067-1509United StatesUSA
  • Phone+1 (615) 861-6000
  • Fax+1 (615) 261-9685
  • Websitehttps://www.acadiahealthcare.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		ACHC:NSQ since
announced		Transaction
value
Adventist Health System/West-Vallejo Behavioral Health Services BusinessAnnounced09 Feb 202109 Feb 2021Announced4.79%--
Data delayed at least 15 minutes, as of Oct 25 2021 21:00 BST.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.